Literature DB >> 27617304

Epigenetic remodeling regulates transcriptional changes between ovarian cancer and benign precursors.

Kevin M Elias1, Megan M Emori2, Thomas Westerling3, Henry Long3, Anna Budina-Kolomets4, Fugen Li3, Emily MacDuffie5, Michelle R Davis1, Alexander Holman6, Brian Lawney6, Matthew L Freedman7, John Quackenbush6, Myles Brown3, Ronny Drapkin8.   

Abstract

Regulation of lineage-restricted transcription factors has been shown to influence malignant transformation in several types of cancer. Whether similar mechanisms are involved in ovarian cancer pathogenesis is unknown. PAX8 is a nuclear transcription factor that controls the embryologic development of the Müllerian system, including the fallopian tubes. Recent studies have shown that fallopian tube secretory epithelial cells (FTSECs) give rise to the most common form of ovarian cancer, high-grade serous ovarian carcinomas (HGSOCs). We designed the present study in order to understand whether changes in gene expression between FTSECs and HGSOCs relate to alterations in PAX8 binding to chromatin. Using whole transcriptome shotgun sequencing (RNA-Seq) after PAX8 knockdown and ChIP-Seq, we show that FTSECs and HGSOCs are distinguished by marked reprogramming of the PAX8 cistrome. Genes that are significantly altered between FTSECs and HGSOCs are enriched near PAX8 binding sites. These sites are also near TEAD binding sites, and these transcriptional changes may be related to PAX8 interactions with the TEAD/YAP1 signaling pathway. These data suggest that transcriptional changes after transformation in ovarian cancer are closely related to epigenetic remodeling in lineage-specific transcription factors.

Entities:  

Year:  2016        PMID: 27617304      PMCID: PMC5017158          DOI: 10.1172/jci.insight.87988

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  50 in total

Review 1.  Pax genes and their role in organogenesis.

Authors:  A Mansouri; G Goudreau; P Gruss
Journal:  Cancer Res       Date:  1999-04-01       Impact factor: 12.701

2.  Conservation of a large protein domain in the segmentation gene paired and in functionally related genes of Drosophila.

Authors:  D Bopp; M Burri; S Baumgartner; G Frigerio; M Noll
Journal:  Cell       Date:  1986-12-26       Impact factor: 41.582

3.  In vivo tumor growth of high-grade serous ovarian cancer cell lines.

Authors:  Anirban K Mitra; David A Davis; Sunil Tomar; Lynn Roy; Hilal Gurler; Jia Xie; Daniel D Lantvit; Horacio Cardenas; Fang Fang; Yueying Liu; Elizabeth Loughran; Jing Yang; M Sharon Stack; Robert E Emerson; Karen D Cowden Dahl; Maria V Barbolina; Kenneth P Nephew; Daniela Matei; Joanna E Burdette
Journal:  Gynecol Oncol       Date:  2015-06-05       Impact factor: 5.482

4.  Overexpression of elafin in ovarian carcinoma is driven by genomic gains and activation of the nuclear factor kappaB pathway and is associated with poor overall survival.

Authors:  Adam Clauss; Vivian Ng; Joyce Liu; Huiying Piao; Moises Russo; Natalie Vena; Qing Sheng; Michelle S Hirsch; Tomas Bonome; Ursula Matulonis; Azra H Ligon; Michael J Birrer; Ronny Drapkin
Journal:  Neoplasia       Date:  2010-02       Impact factor: 5.715

5.  Role for p300 in Pax 8 induction of thyroperoxidase gene expression.

Authors:  R De Leo; S Miccadei; E Zammarchi; D Civitareale
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

6.  Genome-wide analysis of Pax8 binding provides new insights into thyroid functions.

Authors:  Sergio Ruiz-Llorente; Enrique Carrillo Santa de Pau; Ana Sastre-Perona; Cristina Montero-Conde; Gonzalo Gómez-López; James A Fagin; Alfonso Valencia; David G Pisano; Pilar Santisteban
Journal:  BMC Genomics       Date:  2012-04-24       Impact factor: 3.969

7.  Differential expression analysis for sequence count data.

Authors:  Simon Anders; Wolfgang Huber
Journal:  Genome Biol       Date:  2010-10-27       Impact factor: 13.583

8.  Type-specific cell line models for type-specific ovarian cancer research.

Authors:  Michael S Anglesio; Kimberly C Wiegand; Nataliya Melnyk; Christine Chow; Clara Salamanca; Leah M Prentice; Janine Senz; Winnie Yang; Monique A Spillman; Dawn R Cochrane; Karey Shumansky; Sohrab P Shah; Steve E Kalloger; David G Huntsman
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

9.  Elafin drives poor outcome in high-grade serous ovarian cancers and basal-like breast tumors.

Authors:  S I Labidi-Galy; A Clauss; V Ng; S Duraisamy; K M Elias; H-Y Piao; E Bilal; R A Davidowitz; Y Lu; G Badalian-Very; B Györffy; U-B Kang; S Ficarro; S Ganesan; G B Mills; J A Marto; R Drapkin
Journal:  Oncogene       Date:  2014-01-27       Impact factor: 9.867

10.  YAP induces high-grade serous carcinoma in fallopian tube secretory epithelial cells.

Authors:  G Hua; X Lv; C He; S W Remmenga; K J Rodabough; J Dong; L Yang; S M Lele; P Yang; J Zhou; A Karst; R I Drapkin; J S Davis; C Wang
Journal:  Oncogene       Date:  2015-09-14       Impact factor: 9.867

View more
  19 in total

1.  Proteomic analysis of PAX8 alterations provides new insights into its role as a master regulator of migration in high-grade serous ovarian cancer.

Authors:  Tania Gamberi
Journal:  Ann Transl Med       Date:  2019-12

Review 2.  PAX8 in the Junction between Development and Tumorigenesis.

Authors:  Reli Rachel Kakun; Zohar Melamed; Ruth Perets
Journal:  Int J Mol Sci       Date:  2022-07-03       Impact factor: 6.208

3.  The transcription factor PAX8 promotes angiogenesis in ovarian cancer through interaction with SOX17.

Authors:  Daniele Chaves-Moreira; Marilyn A Mitchell; Cristina Arruza; Priyanka Rawat; Simone Sidoli; Robbin Nameki; Jessica Reddy; Rosario I Corona; Lena K Afeyan; Isaac A Klein; Sisi Ma; Boris Winterhoff; Gottfried E Konecny; Benjamin A Garcia; Donita C Brady; Kate Lawrenson; Patrice J Morin; Ronny Drapkin
Journal:  Sci Signal       Date:  2022-04-05       Impact factor: 9.517

4.  PAX8 activates a p53-p21-dependent pro-proliferative effect in high grade serous ovarian carcinoma.

Authors:  Dima Ghannam-Shahbari; Eyal Jacob; Reli Rachel Kakun; Tanya Wasserman; Lina Korsensky; Ofir Sternfeld; Juliana Kagan; Debora Rosa Bublik; Sarit Aviel-Ronen; Keren Levanon; Edmond Sabo; Sarit Larisch; Moshe Oren; Dov Hershkovitz; Ruth Perets
Journal:  Oncogene       Date:  2018-01-30       Impact factor: 9.867

5.  Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.

Authors:  Kate Lawrenson; Fengju Song; Dennis J Hazelett; Siddhartha P Kar; Jonathan Tyrer; Catherine M Phelan; Rosario I Corona; Norma I Rodríguez-Malavé; Ji-Hei Seo; Emily Adler; Simon G Coetzee; Felipe Segato; Marcos A S Fonseca; Christopher I Amos; Michael E Carney; Georgia Chenevix-Trench; Jiyeob Choi; Jennifer A Doherty; Weihua Jia; Gang J Jin; Byoung-Gie Kim; Nhu D Le; Juyeon Lee; Lian Li; Boon K Lim; Noor A Adenan; Mika Mizuno; Boyoung Park; Celeste L Pearce; Kang Shan; Yongyong Shi; Xiao-Ou Shu; Weiva Sieh; Pamela J Thompson; Lynne R Wilkens; Qingyi Wei; Yin L Woo; Li Yan; Beth Y Karlan; Matthew L Freedman; Houtan Noushmehr; Ellen L Goode; Andrew Berchuck; Thomas A Sellers; Soo-Hwang Teo; Wei Zheng; Keitaro Matsuo; Sue Park; Kexin Chen; Paul D P Pharoah; Simon A Gayther; Marc T Goodman
Journal:  Gynecol Oncol       Date:  2019-03-19       Impact factor: 5.482

Review 6.  Unraveling the Mysteries of PAX8 in Reproductive Tract Cancers.

Authors:  Daniele Chaves-Moreira; Patrice J Morin; Ronny Drapkin
Journal:  Cancer Res       Date:  2020-12-23       Impact factor: 13.312

7.  DNA Methylation Profiles of Ovarian Clear Cell Carcinoma.

Authors:  Kelly L Bolton; Francesmary Modugno; Ellen L Goode; Julie M Cunningham; Stacey J Winham; Chen Wang; Britta Weiglt; Zhuxuan Fu; Sebastian M Armasu; Bryan M McCauley; Alison H Brand; Yoke-Eng Chiew; Esther Elishaev; Charlie Gourley; Catherine J Kennedy; Angela Laslavic; Jenny Lester; Anna Piskorz; Magdalena Sekowska; James D Brenton; Michael Churchman; Anna DeFazio; Ronny Drapkin; Kevin M Elias; David G Huntsman; Beth Y Karlan; Martin Köbel; Jason Konner; Kate Lawrenson; Elli Papaemmanuil
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-10-25       Impact factor: 4.090

8.  The PAX8 cistrome in epithelial ovarian cancer.

Authors:  Emily K Adler; Rosario I Corona; Janet M Lee; Norma Rodriguez-Malave; Paulette Mhawech-Fauceglia; Heidi Sowter; Dennis J Hazelett; Kate Lawrenson; Simon A Gayther
Journal:  Oncotarget       Date:  2017-11-27

9.  Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci.

Authors:  Siddhartha P Kar; Emily Adler; Jonathan Tyrer; Dennis Hazelett; Hoda Anton-Culver; Elisa V Bandera; Matthias W Beckmann; Andrew Berchuck; Natalia Bogdanova; Louise Brinton; Ralf Butzow; Ian Campbell; Karen Carty; Jenny Chang-Claude; Linda S Cook; Daniel W Cramer; Julie M Cunningham; Agnieszka Dansonka-Mieszkowska; Jennifer Anne Doherty; Thilo Dörk; Matthias Dürst; Diana Eccles; Peter A Fasching; James Flanagan; Aleksandra Gentry-Maharaj; Rosalind Glasspool; Ellen L Goode; Marc T Goodman; Jacek Gronwald; Florian Heitz; Michelle A T Hildebrandt; Estrid Høgdall; Claus K Høgdall; David G Huntsman; Allan Jensen; Beth Y Karlan; Linda E Kelemen; Lambertus A Kiemeney; Susanne K Kjaer; Jolanta Kupryjanczyk; Diether Lambrechts; Douglas A Levine; Qiyuan Li; Jolanta Lissowska; Karen H Lu; Jan Lubiński; Leon F A G Massuger; Valerie McGuire; Iain McNeish; Usha Menon; Francesmary Modugno; Alvaro N Monteiro; Kirsten B Moysich; Roberta B Ness; Heli Nevanlinna; James Paul; Celeste L Pearce; Tanja Pejovic; Jennifer B Permuth; Catherine Phelan; Malcolm C Pike; Elizabeth M Poole; Susan J Ramus; Harvey A Risch; Mary Anne Rossing; Helga B Salvesen; Joellen M Schildkraut; Thomas A Sellers; Mark Sherman; Nadeem Siddiqui; Weiva Sieh; Honglin Song; Melissa Southey; Kathryn L Terry; Shelley S Tworoger; Christine Walsh; Nicolas Wentzensen; Alice S Whittemore; Anna H Wu; Hannah Yang; Wei Zheng; Argyrios Ziogas; Matthew L Freedman; Simon A Gayther; Paul D P Pharoah; Kate Lawrenson
Journal:  Br J Cancer       Date:  2017-01-19       Impact factor: 7.640

Review 10.  UnPAXing the Divergent Roles of PAX2 and PAX8 in High-Grade Serous Ovarian Cancer.

Authors:  Laura R Hardy; Amrita Salvi; Joanna E Burdette
Journal:  Cancers (Basel)       Date:  2018-08-08       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.